Endocrine Abstracts

Introduction: Nuclear medicine procedures offer a possibility of tracing tumor cells based on their physiology. Gastrin-Releasing Peptide receptor (GRPr) is aberrantly expressed in numerous cancers, among them prostate cancer. Demobesin-15 ([99mTc]DB15) is a novel GRPR-antagonist designed for the evaluation of GRPr expression in different tumors. It has been shown to accumulate in animal prostate cancer models. Hereby, we present our experiences with the first in-hu...